Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Children's Oncology Group
Lund University Hospital
Columbia University
Samsung Medical Center
Masonic Cancer Center, University of Minnesota
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center